analogue

(redirected from Insulin analog)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

analogue

(sometimes US), analog
1. 
a. a physical object or quantity, such as a pointer on a dial or a voltage, used to measure or represent another quantity
b. (as modifier): analogue watch
2. Biology an analogous part or organ
3. Chem
a. an organic chemical compound related to another by substitution of hydrogen atoms with alkyl groups
b. an organic compound that is similar in structure to another organic compound

analogue

(electronics)
(US: "analog") A description of a continuously variable signal or a circuit or device designed to handle such signals. The opposite is "discrete" or "digital".

Analogue circuits are much harder to design and analyse than digital ones because the designer must take into account effects such as the gain, linearity and power handling of components, the resistance, capacitance and inductance of PCB tracks, wires and connectors, interference between signals, power supply stability and more. A digital circuit design, especially for high switching speeds, must also take these factors into account if it is to work reliably, but they are usually less critical because most digital components will function correctly within a range of parameters whereas such variations will corrupt the outputs of an analogue circuit.

See also analogue computer.

analogue

The British and European spelling of analog.
References in periodicals archive ?
The limitations of human premixed insulins have been addressed by using newer insulin analog premix preparations.
This new insulin analog launch may help patients who require higher daily doses of mealtime insulin fit their treatment into their lives and is intended for people already taking mealtime insulin, according to the company.
51,52) It has also been shown that overnight interruption of infusion with a rapid-acting insulin analog is not associated with a higher risk for metabolic decompensation vs regular human insulin.
8) Results from multiple clinical studies have demonstrated the effectiveness of adding a long-acting basal insulin analog to oral therapy in patients with type 2 diabetes.
32) Results from one retrospective analysis of managed care claims data indicated that a switch from administration of insulin therapy by vial/syringe to a prefilled insulin analog pen device was associated with improved medication adherence, fewer claims for hypoglycemic events, reduced emergency department and physician visits, and lower annual treatment costs in patients with type 2 diabetes.
M2 EQUITYBITES-September 17, 2014-Mylan commences two Phase III clinical trials for insulin analog programme, marking important milestone in development of two highly complex products
NovoLog is the trade name for insulin as-part (rDNA origin) injection, a rapid acting insulin analog that was approved by the FDA in 2000.
Premixed insulin or insulin analog formulations combine an intermediate- or long-acting insulin with a short-acting insulin in a fixed-dose regimen and can provide convenience with regard to the number of injections needed for basal-prandial coverage.
NNPI) Novolin human insulin (rDNA origin) and NovoLog (insulin aspart, rDNA origin) injection rapid-acting human insulin analog have been included on the preferred drug list (PDL) of AdvancePCS, a pharmacy benefits manager serving 75 million health plan members.
We are developing two different products in parallel to explore a maximum range of value creating opportunities: recombinant human insulin formulated with PH20 (Insulin-PH20), and a rapid acting insulin analog formulated with PH20 (Analog-PH20).